Overview
- 111 inspections across 101 sites are on record.
- 156 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-27.
At a glance
Inspections
111
Sites
101
Observations
156
Career since
Dec 2013
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| AbbVie Inc. | 27 Apr 2026 | Human Drugs | |
| SGS North America Inc. | 20 Mar 2026 | Human Drugs | On file |
| Primrose Candy Co. | 13 Mar 2026 | Human Drugs | On file |
| Dental Technologies, Inc. | 10 Feb 2026 | Human Drugs | On file |
| Medline Industries, LP | 14 Oct 2025 | Human Drugs | On file |
Sites inspected
AbbVie Inc.North Chicago, United States1 insp.
SGS North America Inc.Lincolnshire, United States1 insp.
Primrose Candy Co.Chicago, United States1 insp.
Dental Technologies, Inc.Lincolnwood, United States1 insp.
Medline Industries, LPWaukegan, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Anders W Evenson5 shared
Gabriel Bermudez-Picart4 shared
Christina A Miller4 shared
Nicholas Z Lu3 shared
Travis V Hull2 shared
Angela C Welker2 shared
Geoffrey K Kilili2 shared
Peng Zhou2 shared
Brian D Nicholson2 shared
Vaishali J Patel2 shared
Full investigator report
Get the verbatim findings behind Michele L Glendenning's 156 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site